Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury. 1995

S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

The present study was designed to investigate the mechanism responsible for endotoxin-induced liver injury, based on the working hypothesis that hepatic macrophages activated by endotoxin play a key role in the development of this injury. At both the protein and the transcription levels, the intravenous administration of endotoxin was shown to have increased the capacity of hepatic macrophages to produce chemical mediators. To inhibit the function of hepatic macrophages, gadolinium chloride (GdCl3), a specific inhibitor of resident hepatic macrophages, was preadministered to rats before endotoxin injection. GdCl3 reduced the elevated glutamic oxaloacetic transamiase and lactate dehydrogenase serum levels produced by endotoxin treatment, suppressed the increased mRNA expression of tumor necrosis factor (TNF-alpha) produced in liver nonparenchymal cells by endotoxin, and then improved the survival rate of lipopolysaccharide-injected rats. These results indicated that hepatic macrophages played a crucial role in liver injury and that TNF-alpha was the most likely factor implicated in the development of endotoxin-induced liver injury. Furthermore, we found that liver injury did not progress during perfusion of endotoxin-pretreated extirpated liver with lactate Ringer's solution, whereas liver perfused with plasma developed remarkable hepatic impairment, which was inhibited almost completely by GdCl3-pretreatment; moreover, addition of heparin to the perfusate also prevented this deterioration. Thus, the present study showed that the activation of hepatic macrophages and factors in the plasma were two essential elements in the occurrence and development of endotoxin-induced liver injury.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005682 Gadolinium An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
April 1994, Hepatology (Baltimore, Md.),
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
February 1990, Hepatology (Baltimore, Md.),
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
May 2024, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
January 2020, Frontiers in immunology,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
September 2004, Transplantation proceedings,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
August 2011, Surgery today,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
August 1990, European journal of biochemistry,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
October 1995, Scandinavian journal of gastroenterology,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
December 1990, The Journal of pathology,
S Fujita, and S Arii, and K Monden, and Y Adachi, and N Funaki, and H Higashitsuji, and M Furutani, and M Mise, and S Ishiguro, and T Kitao
January 2010, Amino acids,
Copied contents to your clipboard!